Increased incidence of FMO1 gene single nucleotide polymorphisms in sporadic amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 7, Issue 4, 2006, Pages 233-240

  Cereda, Cristina ^a   Gabanti, Elisa ^a   Corato, Manuel ^a,d,f   De Silvestri, Annalisa ^b   Alimonti, Dario ^a   Cova, Emanuela ^a   Malaspina, Andrea ^c   Ceroni, Mauro ^a,d,e  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d Policlinico di Monza   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Flavin containing monooxygenases (FMO); Single nucleotide polymorphisms (SNPs); Sporadic amyotrophic lateral sclerosis (sporadic ALS)

Indexed keywords

DIMETHYLANILINE MONOOXYGENASE; DIMETHYLANILINE MONOOXYGENASE 1; GENOMIC DNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC CORRELATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 33847176637     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960600864413     Document Type: Article

References (35)

1. Simpson, E. P., Yen, A. A. and Appel, S. H. (2003) Oxidative stress: A common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opin Rheumatol, 15, pp. 730-736.
2. Bowling, A. C., Schulz, J. B., Brown Jr., R. H. and Beal, M. F. (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem, 61, pp. 2322-2325.
3. Shibata, N., Nagai, R., Uchida, K., Horiuchi, S., Yamada, S. and Hirano, A. (2001) Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res, 917, pp. 97-104.
4. Ferrante, R. J., Browne, S. E., Shinobu, L. A., Bowling, A. C., Baik, M. J. and MacGarvey, U. (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem, 69, pp. 2064-2074.
5. Oteiza, P. I., Uchitel, O. D., Carrasquedo, F., Dubrovski, A. L., Roma, J. C. and Fraga, C. G. (1997) Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res, 22, pp. 535-539.
6. Bogdanov, M., Brown, R. H., Matson, W., Smart, R., Hayden, D. and O'Donnell, H. (2000) Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med, 29, pp. 652-658.
7. Cashman, J. R. (2000) Human flavin-containing mono-oxygenase: Substrate specificity and role in drug metabolism. Curr Drug Metab, 1, pp. 181-191.
8. Phillips, I. R., Dolphin, C. T., Clair, P., Hadley, M. R., Hutt, A. J. and McCombie, R. R. (1995) The molecular biology of the flavin-containing monooxygenases of man. Chem Biol Interact, 96, pp. 17-32.
9. Hernandez, D., Janmohamed, A., Chandan, P., Phillips, I. R. and Shephard, E. A. (2004) Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: Identification of novel gene and pseudogene clusters. Pharmacogenetics, 14, pp. 117-130.
10. Janmohamed, A., Hernandez, D., Phillips, I. R. and Shephard, E. A. (2004) Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos). Biochem Pharmacol, 68, pp. 73-83.
11. Bhamre, S., Bhagwat, S. V., Shankar, S. K., Boyd, M. R. and Ravindranath, V. (1995) Flavin-containing monooxygenase mediated metabolism of psychoactive drugs by human brain microsomes. Brain Res, 672, pp. 276-280.
12. Bhagwat, S. V., Bhamre, S., Boyd, M. R. and Ravindranath, V. (1996) Cerebral metabolism of imipramine and a purified flavin-containing monooxygenase from human brain. Neuropsychopharmacology, 15, pp. 133-142.
13. Bhamre, S. and Ravindranath, V. (1991) Presence of flavin-containing monooxygenase in rat brain. Biochem Pharmacol, 42, pp. 442-444.
14. Suh, J. K., Poulsen, L. L., Ziegler, D. M. and Robertus, J. D. (2000) Redox regulation of yeast flavin-containing monooxygenase. Arch Biochem Biophys, 381, pp. 317-322.
15. Suh, J. K., Poulsen, L. L., Ziegler, D. M. and Robertus, J. D. (1999) Yeast flavin-containing monooxygenase generates oxidizing equivalents that control protein folding in the endoplasmic reticulum. Proc Natl Acad Sci. USA, 96, pp. 2687-2691.
16. Suh, J. K. and Robertus, J. D. (2000) Yeast flavin-containing monooxygenase is induced by the unfolded protein response. Proc Natl Acad Sci. USA, 97, pp. 121-126.
17. Bains, J. S. and Shaw, C. A. (1997) Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev, 25, pp. 335-358.
18. Tohgi, H., Abe, T., Yamazaki, K., Murata, T., Ishizaki, E. and Isobe, C. (1999) Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Neurosci Lett, 260, pp. 204-206.
19. Malaspina, A., Kaushik, N. and de Belleroche, J. (2001) Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem, 77, pp. 132-145.
20. Malaspina, A. and de Belleroche, J. (2004) Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis. Brain Res Res Rev, 45, pp. 213-229.
21. Dolphin, C. T., Riley, J. H., Smith, R. L., Shephard, E. A. and Phillips, I. R. (1997) Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favoured candidate for fish-odour syndrome, determined directly from genomic DNA. Genomics, 46, pp. 260-267.
22. Dolphin, C. T., Beckett, D. J., Janmohamed, A., Cullingford, T. E., Smith, R. L. and Shephard, E. A. (1998) The flavin-containing monooxygenase 2 gene (FMO2) of humans, but not of other primates, encodes a truncated, non-functional protein. J Biol Chem, 273, pp. 30599-30607.
23. Krueger, S. K., Williams, D. E., Yueh, M. F., Martin, S. R., Hines, R. N. and Raucy, J. L. (2002) Genetic polymorphisms of flavin-containing monooxygenase (FMO). Drug Metab Rev, 34, pp. 523-532.
24. Krueger, S. K. and Williams, D. E. (2005) Mammalian flavin-containing monooxygenases: Structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther, 106, pp. 357-387.
25. Hines, R. N., Luo, Z., Hopp, K. A., Cabacungan, E. T., Koukouritaki, S. B. and McCarver, D. G. (2003) Genetic variability at the human FMO1 locus: Significance of a basal promoter yin yang 1 element polymorphism (FMO1*6). J Pharmacol Exp Ther, 306, pp. 1210-1218.
26. Lahiri, D. K., Bye, S., Nurnberger Jr., J. I., Hodes, M. E. and Crisp, M. (1992) A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. J Biochem Biophys Methods, 25, pp. 193-205.
27. Brooks, B. R., Miller, R. G., Swash, M., Munsat, T. L. and World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: Revisited criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 1, pp. 293-299.
28. Terwilliger, J. D. and Ott editors, J. (1994) Handbook of Human Genetic Linkage, Johns Hopkins University Press, Baltimore
29. Gingerich, T. J., Feige, J. J. and LaMarre, J. (2004) AU-rich elements and the control of gene expression through regulated mRNA stability. Anim Health Res Rev, 5, pp. 49-63.
30. Conne, B., Stutz, A. and Vassalli, J. D. (2000) The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology?. Nat Med, 6, pp. 637-641.
31. van Landeghem, G. F., Tabatabaie, P., Beckman, G., Beckman, L. and Andersen, P. M. (1999) Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease. Eur J Neurol, 6, pp. 639-644.
32. Falls, J. G., Ryu, D. Y., Cao, Y., Levi, P. E. and Hodgson, E. (1997) Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids. Arch Biochem Biophys, 342, pp. 212-223.
33. Zhang, A. Q., Mitchell, S. C. and Smith, R. L. (1996) Exacerbation of symptoms of fish-odour syndrome during menstruation. Lancet, 348, pp. 1740-1741.
34. Zhang, J. and Cashman, J. R. (2006) Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metab Dispos, 34, pp. 19-26.
35. Mayeux, R. (2005) Mapping the new frontier: Complex genetic disorders. J Clin Invest, 115, pp. 1404-1407.